Actively Recruiting
Immediate Implant Placement in the Posterior Region Combining Sealing Socket Abutment and Peri-implant Socket Filling.
Led by University of Liege · Updated on 2023-02-23
30
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary endpoint of this study is to compare the soft tissue contour changes after immediate implant placement combined to peri-implant socket filling with a sealing socket abutment (SSA) versus a standard healing abutment. The hypothesis is that the SSA better preserves the alveolar ridge profile in the cervical region compared to a conventional healing abutment. The secondary objectives aim to evaluate 3D hard tissue changes, peri-implant bone remodeling, soft tissue health, esthetic outcomes and the patients related outcome measures.
CONDITIONS
Official Title
Immediate Implant Placement in the Posterior Region Combining Sealing Socket Abutment and Peri-implant Socket Filling.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Good general health (ASA I/II)
- Age over 18 years
- Smoker less than 10 cigarettes per day
- One hopeless tooth in the posterior region
- Healthy periodontal condition
- Presence of at least 2 mm of keratinized gingiva
- Intact buccal bone wall
- Adequate plaque control (FMPS ≤ 25%)
- Adequate bone quantity for immediate implant (apical bone height ≥ 5 mm or interradicular septum present)
- Provided written consent
You will not qualify if you...
- Auto-immune disease or immunocompromised status
- Uncontrolled diabetes
- Use of steroids or biphosphonates
- Local or systemic infection requiring treatment before study entry
- Pregnancy or breastfeeding
- Alcoholism or chronic drug abuse
- Bone condition requiring angulated abutment
- Untreated local inflammation
- Presence of cyst
- Mucosal disease or oral lesions
- Previous local irradiation therapy
- Oral communication with sinus after tooth extraction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Liège
Liège, Belgium, 4000
Actively Recruiting
Research Team
B
Bruno De Carvalho, DDS, Ms, PhD Fellow
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here